Beijing Balance Medical Technology Co Ltd
SSE:688198
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Beijing Balance Medical Technology Co Ltd
SSE:688198
|
14B CNY |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
399.2B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202.4B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.1B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.1B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
74.2B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.2B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Beijing Balance Medical Technology Co Ltd
Glance View
Beijing Balance Medical Technology Co Ltd, a pivotal player in the Chinese healthcare landscape, has carved out a niche by embracing a fusion of innovation and practicality within the medical technology sector. Founded to seamlessly integrate cutting-edge technology with healthcare delivery, the company has successfully positioned itself within the burgeoning market for medical devices and equipment. Balance Medical’s core operations revolve around the design, development, and production of high-precision medical instruments that cater to a wide array of medical needs, ranging from diagnostics to therapeutic equipment. They have often set themselves apart through their commitment to research and development, driving the creation of state-of-the-art solutions that streamline medical procedures and enhance patient care. The company's revenue model hinges on a robust portfolio of products, which includes advanced imaging systems, surgical equipment, and monitoring devices that are indispensable in modern medical facilities. Through strategic partnerships and collaborations with healthcare institutions and medical professionals, Beijing Balance Medical Technology Co Ltd ensures a continuous feedback loop, allowing them to refine and expand their offerings. Moreover, their adeptness at navigating the regulatory landscape in China provides a steady flow of approvals and certifications, facilitating swift market entry and adoption. By focusing on both domestic demand and exploring international markets, the company generates returns not only through direct sales but also by licensing their technology and forming joint ventures, anchoring its position as a forward-thinking entity in the medical technology arena.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Beijing Balance Medical Technology Co Ltd is 30.5%, which is above its 3-year median of 30.3%.
Over the last 3 years, Beijing Balance Medical Technology Co Ltd’s Net Margin has increased from 24.4% to 30.5%. During this period, it reached a low of 24.4% on Sep 30, 2022 and a high of 32.6% on Jun 30, 2025.